Aetna Updated CPB 0106 for Fetal Echocardiography — What Billing Teams Need to Know in 2025
Aetna, a CVS Health company, modified CPB 0106 covering fetal echocardiography and magnetocardiography, effective September 26, 2025. This coverage policy update affects CPT codes 76825, 76826, 76827, 76828, and add-on code +93325, plus Category III codes 0475T–0478T for fetal magnetocardiography. If your practice bills fetal echo for high-risk obstetric patients, audit your charge capture and ICD-10 pairing against the updated criteria before September 26.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Fetal Echocardiography and Magnetocardiography |
| Policy Code | CPB 0106 |
| Change Type | Modified |
| Effective Date | September 26, 2025 |
| Impact Level | High |
| Specialties Affected | Maternal-fetal medicine, OB/GYN, pediatric cardiology, diagnostic radiology |
| Key Action | Verify each fetal echo claim pairs a covered indication from the updated list with the correct CPT code before September 26, 2025 |
Aetna Fetal Echocardiography Coverage Criteria and Medical Necessity Requirements 2025
CPB 0106 is Aetna's coverage policy governing when fetal echocardiography is medically necessary. The updated policy covers fetal echocardiograms with Doppler and color flow mapping (CPT 76825, 76827, +93325) after 12 weeks gestation — but only when at least one of 20 specific indications is documented. Medical necessity is not assumed. You need the right diagnosis to get paid.
The indications fall into several clinical buckets: maternal autoimmune disease, maternal diabetes, fetal structural findings, genetic risk, teratogen exposure, and fetal vascular anomalies.
Maternal conditions that establish medical necessity include:
| # | Covered Indication |
|---|---|
| 1 | Type 1 diabetes or pregestational type 2 diabetes on insulin during the first trimester |
| 2 | Systemic lupus erythematosus (ICD-10 M32.0–M32.9) |
| 3 | Autoimmune antibodies anti-Ro (SSA) or anti-La (SSB) |
| 4 | Seizure disorders — even when the member is not currently taking anti-seizure medication. This is a notable detail. Aetna covers the echo based on the diagnosis, not current medication status. |
| 5 | Sjögren's syndrome (M35.0) |
Fetal findings and structural indications include:
| # | Covered Indication |
|---|---|
| 1 | Nuchal translucency of 3.5 mm or greater in the first trimester |
| 2 | Abnormal or incomplete cardiac evaluation on anatomic scan or 4-chamber study |
| 3 | Suspected or documented fetal arrhythmia |
| 4 | Ductus arteriosus dependent lesions or complex congenital heart disease |
| 5 | Umbilical cord varix with suspicion of fetal hydrops |
| 6 | Persistent right umbilical vein or single umbilical artery |
| 7 | Non-immune fetal hydrops or unexplained severe polyhydramnios |
| 8 | Other cardiac structural abnormalities found on fetal ultrasound |
| 9 | Monochorionic twins or suspected twin-twin transfusion syndrome |
Conception method also qualifies: pregnancies conceived by IVF or ICSI are a covered indication. Make sure your team is capturing this in the chart and pairing it with the right ICD-10 at claim submission.
Teratogen exposure covers:
| # | Covered Indication |
|---|---|
| 1 | Anti-seizure medications |
| 2 | Excessive alcohol intake (F10.20–F10.29) |
| 3 | Lithium |
| 4 | Paroxetine (Paxil) |
| 5 | Retinoids |
Repeat studies (CPT 76826, 76828) are covered under a separate set of criteria. These are not automatic follow-ups. Medical necessity for a repeat study must be established independently — usually by findings on the initial study or by ongoing maternal antibody status requiring serial surveillance.
Aetna covers serial Doppler fetal echocardiography for congenital heart block monitoring in mothers with Sjögren's syndrome or anti-Ro/anti-La antibodies. The protocol is specific: every one to two weeks starting at 16 weeks gestation through 28 weeks, then every other week through 32 weeks. That cadence needs to be documented in the order and in the billing record. Deviations from this schedule increase denial risk.
NSAIDs use in the late second or third trimester is also a covered indication for a repeat study. If your ordering physician is prescribing NSAIDs and the patient has a documented reason for fetal echo, that repeat qualifies.
The real issue with prior authorization: this policy doesn't explicitly state prior auth requirements within the criteria summary, but high-cost imaging like fetal echo almost always requires it under commercial Aetna plans. Confirm your specific plan contract before assuming routine approval. If your compliance officer hasn't reviewed your prior authorization workflows against this policy, that's the first conversation to have before the effective date.
Aetna Fetal Echocardiography Exclusions and Non-Covered Indications
The policy is explicit on one exclusion: when a 4-chamber view is adequate and there are no other cardiac abnormalities, a fetal echocardiogram is not medically necessary.
This is a claim denial waiting to happen. If a routine anatomy scan shows a normal 4-chamber view with no documented risk factors, billing 76825 or 76827 will not survive a medical necessity review. Document the specific indication — don't rely on "abnormal anatomy scan" without clinical detail.
Fetal magnetocardiography (CPT 0475T, 0476T, 0477T, 0478T) falls under the experimental/investigational classification in this policy. CPT 0541T and 0542T, for myocardial imaging by magnetocardiography, are also listed as not covered for routine use. These codes are grouped under "deep learning-based models/networks" in the policy — meaning Aetna treats them as unproven technology. Don't bill these expecting reimbursement on standard commercial plans.
Coverage Indications at a Glance
| Indication | Status | Relevant CPT Codes | Notes |
|---|---|---|---|
| Type 1 or pregestational type 2 diabetes, on insulin in first trimester | Covered | 76825, 76827, +93325 | ICD-10 E10.x–E13.x (not gestational diabetes) |
| Systemic lupus erythematosus | Covered | 76825, 76827, +93325 | M32.0–M32.9 |
| Anti-Ro (SSA) or anti-La (SSB) antibodies | Covered | 76825, 76827, +93325 | Repeat studies also covered |
| Sjögren's syndrome — serial fetal heart block surveillance | Covered (repeat) | 76826, 76828 | Every 1–2 weeks 16–28 wks; every other week 28–32 wks |
| First-degree family history of congenital heart disease | Covered | 76825, 76827, +93325 | Applies to fetus's first-degree relatives |
| Nuchal translucency ≥3.5 mm in first trimester | Covered | 76825, 76827, +93325 | Must be documented from first-trimester scan |
| Abnormal or incomplete 4-chamber study | Covered | 76825, 76827, +93325 | Normal 4-chamber view = not covered if no other indications |
| Ductus arteriosus dependent lesions / complex CHD | Covered | 76825, 76826, 76827, 76828, +93325 | Repeat studies also covered |
| Umbilical cord varix with suspected fetal hydrops | Covered | 76825, 76827, +93325 | Hydrops suspicion must be documented |
| IVF or ICSI conception | Covered | 76825, 76827, +93325 | Confirm chart documents ART method |
| Persistent right umbilical vein | Covered | 76825, 76827, +93325 | |
| Single umbilical artery | Covered | 76825, 76827, +93325 | |
| Suspected or known fetal chromosomal abnormalities | Covered | 76825, 76827, +93325 | |
| Suspected or documented fetal arrhythmia | Covered | 76825, 76827, +93325 | |
| Familial inherited disorders (e.g., Marfan syndrome) | Covered | 76825, 76827, +93325 | |
| Monochorionic twins | Covered | 76825, 76827, +93325 | |
| Multiple gestation with suspected twin-twin transfusion syndrome | Covered | 76825, 76827, +93325 | |
| Seizure disorders (even off medication) | Covered | 76825, 76827, +93325 | Diagnosis alone qualifies — no active Rx required |
| Non-immune fetal hydrops or unexplained severe polyhydramnios | Covered | 76825, 76827, +93325 | |
| Teratogen exposure (anti-seizure meds, alcohol, lithium, paroxetine, retinoids) | Covered | 76825, 76827, +93325 | F10.20–F10.29 for alcohol; verify drug documentation in chart |
| Other cardiac structural abnormalities on fetal ultrasound | Covered | 76825, 76827, +93325 | |
| Structural heart disease with hemodynamic compromise | Covered (repeat) | 76826, 76828 | |
| Tachycardia (non-sinus) or heart block | Covered (repeat) | 76826, 76828 | |
| NSAID use in late second or third trimester | Covered (repeat) | 76826, 76828 | |
| Normal 4-chamber view, no other cardiac indications | Not Covered | 76825, 76827 | Explicit exclusion in policy |
| Fetal magnetocardiography (general use) | Experimental | 0475T, 0476T, 0477T, 0478T | Not covered under standard commercial plans |
| MCG for cardiac ischemia detection | Experimental | 0541T, 0542T |
Aetna Fetal Echocardiography Billing Guidelines and Action Items 2025
| # | Action Item |
|---|---|
| 1 | Audit your active fetal echo orders before September 26, 2025. Pull all open orders for CPT 76825, 76826, 76827, and 76828. Confirm each one maps to a covered indication in the updated CPB 0106 criteria. If the chart only says "routine high-risk OB," that's not enough. The specific indication must be documented. |
| 2 | Update your ICD-10 pairing protocols now. The policy recognizes a wide range of diagnosis codes — seizure disorders (G40.001–G40.919), SLE (M32.0–M32.9), alcohol dependence (F10.20–F10.29), diabetes (E10.x–E13.x), Sjögren's (M35.0), and many more. Build or update your charge capture crosswalk so the correct ICD-10 code is required before 76825 or 76827 goes to claim. |
| 3 | Flag the seizure disorder indication specifically. This catches billing teams off guard. Aetna covers fetal echo for members with seizure disorders even when they're not on anti-seizure medication at the time of the study. Make sure your intake and order forms capture epilepsy history — not just current medications. |
| 4 | Separate your initial and repeat study documentation. CPT 76826 and 76828 (repeat studies) require independent medical necessity. The strongest repeat indications are: structural heart disease with hemodynamic compromise, tachycardia other than sinus, heart block, and NSAID use in late pregnancy. For Sjögren's/anti-Ro/anti-La patients, document the specific surveillance schedule — every one to two weeks from 16 to 28 weeks, then every other week through 32 weeks. |
| 5 | Do not submit 0475T–0478T or 0541T–0542T expecting fetal echocardiography reimbursement. Aetna's fetal magnetocardiography billing policy treats these codes as experimental. These are not covered under CPB 0106 for standard commercial plans. If you're performing magnetocardiography, have a frank conversation with your compliance officer before any claims go out. |
| 6 | Confirm prior authorization requirements on individual plan contracts. The policy criteria define medical necessity, but prior auth requirements vary by plan. High-volume maternal-fetal medicine practices billing these codes should verify PA requirements with Aetna before September 26. A claim denial on a covered indication is often a PA workflow failure — not a coverage issue. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Fetal Echocardiography Under CPB 0106
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 76825 | CPT | Echocardiography, fetal, cardiovascular system, real time with image documentation (2D), with or without M-mode recording |
| 76826 | CPT | Echocardiography, fetal, cardiovascular system, real time with image documentation (2D); follow-up or repeat study |
| 76827 | CPT | Doppler echocardiography, fetal, cardiovascular system, pulsed wave and/or continuous wave with spectral display |
| 76828 | CPT | Doppler echocardiography, fetal, cardiovascular system; follow-up or repeat study |
| +93325 | CPT | Doppler echocardiography color flow velocity mapping (add-on code — list separately in addition to echo codes) |
Experimental / Not Covered Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| 0475T | Category III CPT | Recording of fetal magnetic cardiac signal using at least 3 channels; patient recording and storage | Experimental — not covered under standard commercial plans |
| 0476T | Category III CPT | Recording of fetal magnetic cardiac signal; patient recording, data scanning, with raw electronic signal transfer of data and storage | Experimental |
| 0477T | Category III CPT | Recording of fetal magnetic cardiac signal; signal extraction, technical analysis, and result | Experimental |
| 0478T | Category III CPT | Recording of fetal magnetic cardiac signal; review, interpretation, report by physician or other qualified health care professional | Experimental |
| 0541T–0542T | Category III CPT | Myocardial imaging by magnetocardiography (MCG) for detection of cardiac ischemia, by signal acquisition | Experimental |
Key ICD-10-CM Diagnosis Codes
| Code Range | Description |
|---|---|
| E10.10–E13.9 | Diabetes mellitus (do not use gestational diabetes codes) |
| F10.20–F10.29 | Alcohol dependence |
| G40.001–G40.919 | Epilepsy and recurrent seizures |
| M32.0–M32.9 | Systemic lupus erythematosus |
| M35.0 | Sicca syndrome (Sjögren's) |
| M34.0–M34.9 | Systemic sclerosis (scleroderma) |
| M05.40–M06.9 | Rheumatoid arthritis |
| D68.61 | Antiphospholipid syndrome |
| L93.0–L93.2 | Lupus erythematosus (cutaneous) |
| O99.111–O99.119 | Other diseases of blood and immune mechanism complicating pregnancy |
| I34.0–I37.9 | Mitral, aortic, tricuspid, and pulmonary valve disorders |
| I50.1–I50.9 | Heart failure |
| I51.0–I51.9 | Complications and ill-defined descriptions of heart disease |
| I42.3 | Endomyocardial (eosinophilic) disease |
| I42.4 | Endocardial fibroelastosis |
| I42.6 | Alcoholic cardiomyopathy |
| I78.0 | Hereditary hemorrhagic telangiectasia |
| B97.10, B97.89 | Viral infections as cause of diseases classified elsewhere |
The full ICD-10-CM code list under CPB 0106 contains 472 codes. The ranges above represent the highest-volume categories for fetal echocardiography billing. Review the full list at the Aetna policy source for less common indications.
Get the Full Picture for CPT 76825
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.